Address resolution protocol optimization

This paper proposes an improved Address Resolution Protocol (ARP) for Ethernet-based networks. In the proposed alternative method, the ARP request packets are not broadcasted but instead unicasted to an ARP server which will have all the mappings of all the hosts connected to the network. This significantly reduces ARP signaling and processing overhead. The ARP server obtains the mappings through a novel passive method that does not introduce additional overhead in the network. Furthermore, the use of the ARP server makes it much easier to secure the network against certain attacks like ARP poisoning

A Systematic Review on Image Data Protection Methods

Securing data is the main goal of any data security system (DSS). Valuable data must be protected all the time and stored in a very highly secure data storage device. This need has become more critical due to the continuous growth of data size.  Furthermore, non-text data in the form of images, audio, and videos can now be transferred and processed easily and thus become part of sensitive data that needs to be protected. Since there is a need to secure and protect data in any form in order to keep them private and valid, it is expected that there would be many attempts already that have been proposed in the literature for this purpose. This paper reviews a group of these proposed strategies and methods that have been applied to different kinds of DSSs. Challenges and future trends of DSSs are also discussed. A number of main findings are grouped and organized as follows: (1) there are many different kinds of security techniques, each of which offers varying degrees of performance in terms of the amount of data and information that can be managed securely, (2) depending on the architecture of the proposed method, the tactics or strategies of the security system, the kinds of DSSs, as well as a few other factors, some methods are more appropriate for the storage of certain categories of data than others

Information Aggregation using the Cameleon# Web Wrapper

Cameleon# is a web data extraction and management tool that provides information aggregation with advanced capabilities that are useful for developing value-added applications and services for electronic business and electronic commerce. To illustrate its features, we use an airfare aggregation example that collects data from eight online sites, including Travelocity, Orbitz, and Expedia. This paper covers the integration of Cameleon# with commercial database management systems, such as MS SQL Server, and XML query languages, such as XQuery

Concepts for slicing object-oriented programs

This paper proposes several concepts that form the basis for slicing object-oriented programs. In the case of object-oriented languages, new relations occur between language constructs such as classes, methods, and messages. Thus new forms of dependencies have to be considered in addition to the traditional control and data dependencies that form the basis of most software maintenance tools that are currently available for maintaining procedure-oriented programs. We show how the proposed slicing concepts can be applied within the software maintenance process by giving an illustration through an example of Java program

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Background: The EMPA KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population. Methods: EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110. Findings: Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5–2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62–0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The between-group difference in chronic eGFR slopes (ie, from 2 months to final follow-up) was 1·37 mL/min per 1·73 m2 per year (95% CI 1·16–1·59), representing a 50% (42–58) reduction in the rate of chronic eGFR decline. This relative effect of empagliflozin on chronic eGFR slope was similar in analyses by different primary kidney diseases, including in explorations by type of glomerular disease and diabetes (p values for heterogeneity all >0·1). Interpretation: In a broad range of patients with chronic kidney disease at risk of progression, including a wide range of non-diabetic causes of chronic kidney disease, empagliflozin reduced risk of kidney disease progression. Relative effect sizes were broadly similar irrespective of the cause of primary kidney disease, suggesting that SGLT2 inhibitors should be part of a standard of care to minimise risk of kidney failure in chronic kidney disease. Funding: Boehringer Ingelheim, Eli Lilly, and UK Medical Research Council

Information Aggregation using the Caméléon # Web Wrapper

Abstract. Caméléon # is a web data extraction and management tool that provides information aggregation with advanced capabilities that are useful for developing value-added applications and services for electronic business and electronic commerce. To illustrate its features, we use an airfare aggregation example that collects data from eight online sites, including Travelocity, Orbitz, and Expedia. This paper covers the integration of Caméléon # with commercial database management systems, such as MS SQL Server, and XML query languages, such as XQuery.

Information Aggregation using the Caméléon # Web Wrapper

For more information, please visit our website a

Information Aggregation using the Cameleon# Web Wrapper

Cameleon# is a web data extraction and management tool that provides information aggregation with advanced capabilities that are useful for developing value-added applications and services for electronic business and electronic commerce. To illustrate its features, we use an airfare aggregation example that collects data from eight online sites, including Travelocity, Orbitz, and Expedia. This paper covers the integration of Cameleon# with commercial database management systems, such as MS SQL Server, and XML query languages, such as XQuery.Cameleon#, web data extraction, web data management,

Inspection data analysis for the assessment of corroded pipelines

An initiative to provide a fresh perspective on the latest development of water management and technology, aligned with integrated water resources management